Amrutanjan Health Care Q3 Results 2025 on 15 Feb, 2025: profit rise by 10.32% YOY, profit at ₹19.25 crore and revenue at ₹122.75 crore
Amrutanjan Health Care Q3 Results 2025 on 15 Feb, 2025: Revenue increased by 4.92% YoY & profit increased by 10.32% YoY, profit at ₹19.25 crore and revenue at ₹122.75 crore
Amrutanjan Health Care Q3 Results 2025:Amrutanjan Health Care declared their Q3 results on 12 Feb, 2025, revealing a notable growth in their financial performance. The topline increased by 4.92% year-over-year, with profit rising by 10.32% to ₹19.25 crore, while revenue reached ₹122.75 crore.
In comparison to the previous quarter, Amrutanjan experienced significant growth, with revenue up by 11.67% and profit soaring by 63.14%. This marks a strong upward trend for the company as it navigates the current economic landscape.
Amrutanjan Health Care Q3 Results
The company's operating income also saw impressive results, rising by 81.42% quarter-over-quarter and 8.4% year-over-year. These figures indicate robust operational efficiency and a strong market position.
Earnings per share (EPS) for Q3 stood at ₹6.66, reflecting an increase of 10.26% year-over-year, demonstrating the company's commitment to delivering value to its shareholders.
Amrutanjan Health Care has faced some challenges recently, with a -5.75% return in the last week, -13.53% over the past six months, and a -12.18% year-to-date return. Investors will be looking to see how the company addresses these market fluctuations.
Currently, Amrutanjan Health Care has a market capitalization of ₹1773.07 crore, with a 52-week high of ₹862.6 and a low of ₹596, indicating a volatile but potentially lucrative investment opportunity.
In addition to its financial results, the company has declared an interim dividend of ₹1.0, with the record date set for 18 Feb, 2025, and the ex-dividend date also on 18 Feb, 2025, providing further incentive for shareholders.
Amrutanjan Health Care Financials
| Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 122.75 | 109.92 | +11.67% | 116.99 | +4.92% |
| Selling/ General/ Admin Expenses Total | 31.26 | 29.43 | +6.22% | 25.68 | +21.73% |
| Depreciation/ Amortization | 1.66 | 1.65 | +0.61% | 1.58 | +5.06% |
| Total Operating Expense | 101.07 | 97.97 | +3.16% | 97 | +4.2% |
| Operating Income | 21.68 | 11.95 | +81.42% | 20 | +8.4% |
| Net Income Before Taxes | 25.99 | 15.94 | +63.05% | 23.71 | +9.62% |
| Net Income | 19.25 | 11.8 | +63.14% | 17.45 | +10.32% |
| Diluted Normalized EPS | 6.66 | 4.08 | +63.24% | 6.04 | +10.26% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
- Top Gainers
- Top Losers
- 52 Week High